Danshen Modulates Nrf2-mediated Signaling Pathway in Cisplatin-induced Renal Injury

Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days befo...

Full description

Saved in:
Bibliographic Details
Published inCurrent medical science Vol. 37; no. 5; pp. 761 - 765
Main Author 曹思思;颜苗;侯振彦;陈莹;蒋云生;樊新荣;方平飞;张毕奎
Format Journal Article
LanguageEnglish
Published Wuhan Huazhong University of Science and Technology 01.10.2017
Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China
School of Pharmaceutical Sciences, Central South University, Changsha 410013, China%Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China%Department of Nephrology, the Second Xiangya Hospital Central South University, Changsha 410011, China%Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes(GSH-Px and SOD) and peroxidative product(MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes(GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway.
AbstractList Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes (GSH-Px and SOD) and peroxidative product (MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes (GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway.
Summary Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes (GSH-Px and SOD) and peroxidative product (MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes (GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway.
Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes (GSH-Px and SOD) and peroxidative product (MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes (GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway.Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes (GSH-Px and SOD) and peroxidative product (MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes (GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway.
Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes(GSH-Px and SOD) and peroxidative product(MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes(GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway.
Author 曹思思;颜苗;侯振彦;陈莹;蒋云生;樊新荣;方平飞;张毕奎
AuthorAffiliation Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha 410011, China;School of Pharmaceutical Sciences, Central South University, Changsha 410013, China;Department of Nephrology, the Second Xiangya Hospital, Central South University, Changsha 410011, China;Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
AuthorAffiliation_xml – name: Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China;School of Pharmaceutical Sciences, Central South University, Changsha 410013, China%Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China%Department of Nephrology, the Second Xiangya Hospital Central South University, Changsha 410011, China%Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
Author_xml – sequence: 1
  fullname: 曹思思;颜苗;侯振彦;陈莹;蒋云生;樊新荣;方平飞;张毕奎
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29058292$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtv3CAURlGVqnm0P6CbyuqqUkTLBRvMspq-IqUPNdkjzMPD1IMnYCuZfx8iT1qpi6wA6Zx7L989RUdxjA6h10DeAyHiQwZoJMcEBIaWAIZn6ASkZBhYQ4_KnQuKiWDsGJ3mvCGkEZzWL9AxlaRpqaQn6OqTjnntYvV9tPOgJ5erH8lTvHU2lJetrkIf9RBiX_3S0_pW76sQq1XIuwKHiEO0synYb1eo6iJu5rR_iZ57PWT36nCeoesvn69X3_Dlz68Xq4-X2NRETFhwq1tRg-WG8lYI6jvPPDjiDHW11KIDTrVz4J0nDLxorSXMcmcMdFazM3S-lL3V0evYq804pzJFVtNm_8fe3XXK0ZINaQjIQr9b6F0ab2aXJ7UN2bhh0NGNc1Ygm7qmrOAFfXNA567koHYpbHXaq8fUCiAWwKQx5-S8MmEqcYxxSjoMCoh62I9a9qPKDOphPwqKCf-Zj8Wfcuji5MLG3qV_H31KentotB5jf1O8v524YJIzTiS7B0V_rVI
CitedBy_id crossref_primary_10_1253_circj_CJ_23_0864
crossref_primary_10_3389_fphar_2023_1153297
crossref_primary_10_3389_fphar_2020_619201
crossref_primary_10_1155_2022_9275056
crossref_primary_10_1007_s11255_020_02485_z
crossref_primary_10_1007_s12011_021_02913_w
crossref_primary_10_1186_s12906_021_03398_9
Cites_doi 10.1371/journal.pone.0074318
10.1124/jpet.110.170084
10.1007/s11596-016-1540-8
10.1089/acm.2011.0041
10.1016/j.lfs.2004.02.034
10.1038/ki.2013.248
10.1038/ki.2015.328
10.1016/j.phymed.2015.03.003
10.1007/s00204-006-0173-2
10.1002/biof.1094
10.1016/S0254-6272(15)30102-3
10.1371/journal.pone.0101668
10.1016/j.etp.2008.09.003
10.3390/cancers8020021
10.1016/j.jep.2011.11.046
10.3390/ijms131013621
10.1016/S2221-1691(12)60112-9
10.1016/j.neulet.2013.02.069
10.1038/ki.2013.330
10.2215/CJN.08070715
10.1152/ajprenal.2000.278.5.F726
10.3390/toxins2112490
10.1016/j.intimp.2016.06.024
10.1016/j.jep.2013.11.025
10.1016/S0272-6386(86)80112-3
10.1038/ki.2009.157
10.1002/jbt.21833
ContentType Journal Article
Copyright Huazhong University of Science and Technology and Springer-Verlag GmbH Germany 2017
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Huazhong University of Science and Technology and Springer-Verlag GmbH Germany 2017
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/s11596-017-1801-1
DatabaseName 中文科技期刊数据库
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Danshen Modulates Nrf2-mediated Signaling Pathway in Cisplatin-induced Renal Injury
EISSN 1993-1352
2523-899X
EndPage 765
ExternalDocumentID tjykdxxb_e201705019
29058292
10_1007_s11596_017_1801_1
673963609
Genre Journal Article
GrantInformation_xml – fundername: grants from the National Natural Science Foundation of China
  funderid: (.81202985 and 81573686)
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJNI
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
DPUIP
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
-05
-0E
-EM
-SE
-S~
2JN
2JY
406
5VR
92M
9D9
9DE
AACDK
AAHNG
AAIAL
AAJBT
AANZL
AASML
AATNV
AAUYE
AAXDM
AAYZH
ABAKF
ABDZT
ABECU
ABHQN
ABKZE
ABMQK
ABSXP
ABTEG
ABTKH
ABWNU
ABXPI
ACAOD
ACDTI
ACHSB
ACMDZ
ACMLO
ACOKC
ACZOJ
ADKNI
ADRFC
ADTPH
AEFQL
AEJRE
AEMSY
AESKC
AEVLU
AFBBN
AFLOW
AFQWF
AFUIB
AGJBK
AGMZJ
AGQEE
AGRTI
AHSBF
AIAKS
AIGIU
AILAN
AITGF
AMXSW
AMYLF
AMYQR
AOCGG
AXYYD
BDATZ
CAJEE
DDRTE
DNIVK
EBLON
EIOEI
FERAY
FFXSO
FIGPU
FINBP
FSGXE
GNWQR
GRRUI
IKXTQ
IWAJR
JZLTJ
LLZTM
NPVJJ
PT4
Q--
RHV
RT5
SCLPG
SDE
SISQX
SJYHP
SNPRN
SOHCF
SRMVM
SSLCW
STPWE
T8U
TGQ
U1F
U1G
U5E
U5O
UOJIU
UTJUX
UZXMN
VFIZW
YLTOR
Z87
ZMTXR
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
ABQSL
H13
NPM
7X8
4A8
93N
ADHKG
AGQPQ
PSX
ID FETCH-LOGICAL-c407t-76da8741d6c268772fbf3f1e0ec2e49a7b162aee1fef031f78dd03d6ecc1bda3
ISSN 1672-0733
2096-5230
1993-1352
IngestDate Thu May 29 04:06:48 EDT 2025
Fri Jul 11 04:47:48 EDT 2025
Wed Feb 19 02:44:02 EST 2025
Thu Apr 24 23:08:56 EDT 2025
Tue Jul 01 04:14:36 EDT 2025
Fri Feb 21 02:37:18 EST 2025
Wed Feb 14 09:55:25 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords nephrotoxicity
cisplatin
Nrf2
Danshen
oxidative stress
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c407t-76da8741d6c268772fbf3f1e0ec2e49a7b162aee1fef031f78dd03d6ecc1bda3
Notes Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes(GSH-Px and SOD) and peroxidative product(MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes(GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway.
cisplatin; nephrotoxicity; Danshen; Nrf2; oxidative stress
42-1679/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 29058292
PQID 1954423170
PQPubID 23479
PageCount 5
ParticipantIDs wanfang_journals_tjykdxxb_e201705019
proquest_miscellaneous_1954423170
pubmed_primary_29058292
crossref_citationtrail_10_1007_s11596_017_1801_1
crossref_primary_10_1007_s11596_017_1801_1
springer_journals_10_1007_s11596_017_1801_1
chongqing_primary_673963609
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-10-01
PublicationDateYYYYMMDD 2017-10-01
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Wuhan
PublicationPlace_xml – name: Wuhan
– name: China
PublicationTitle Current medical science
PublicationTitleAbbrev CURR MED SCI
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL Journal of Huazhong University of Science and Technology(Medical Science)
PublicationYear 2017
Publisher Huazhong University of Science and Technology
Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China
School of Pharmaceutical Sciences, Central South University, Changsha 410013, China%Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China%Department of Nephrology, the Second Xiangya Hospital Central South University, Changsha 410011, China%Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
Publisher_xml – name: Huazhong University of Science and Technology
– name: Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China
– name: School of Pharmaceutical Sciences, Central South University, Changsha 410013, China%Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China%Department of Nephrology, the Second Xiangya Hospital Central South University, Changsha 410011, China%Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
References Yin, Yin, Yang (CR12) 2014; 151
Oh, Kim, Choi (CR24) 2014; 85
Chong, Zhou, Razmovski-Naumovski (CR28) 2013; 543
Zhang, Jiang, Ye (CR29) 2012; 13
Santos, Catao, Martins (CR7) 2007; 81
Noel, Hamad, Rabb (CR21) 2015; 88
Lu, Jin, Ma (CR13) 2015; 35
Kang, Oh, Sohn (CR16) 2004; 75
Xu, Shen, Bi (CR11) 2016; 38
Chirino, Pedraza-Chaverri (CR6) 2009; 61
Liu, Grigoryev, Crow (CR9) 2009; 76
Aleksunes, Goedken, Rockwell (CR10) 2010; 335
Zou, Lu, Mao (CR17) 2012; 18
Lee, Jeong, Yang (CR25) 2012; 139
Yu, Wang, Akinyi (CR27) 2015; 8
Hoek, Bloemendal, van der Velden (CR1) 2016; 8
Jin, Li, Zhao (CR18) 2015; 22
Darwish, Abo-Youssef, Khalaf (CR19) 2016; 31
Cornejo, Vargas, Videla (CR22) 2013; 39
Zhou, Qu, Li (CR26) 2014; 9
Guan, Ma, Zhang (CR14) 2013; 8
Latcha, Jaimes, Patil (CR2) 2016; 11
Miller, Tadagavadi, Ramesh (CR5) 2010; 2
Ries, Klastersky (CR3) 1986; 8
Shelton, Park, Copple (CR20) 2013; 84
Li, Zhang, Ma (CR15) 2014; 2014
Lv, Yao, Wang (CR8) 2016; 36
Arunkumar, Viswanatha, Radheshyam (CR4) 2012; 2
Shiraishi, Curtis, Truong (CR23) 2000; 278
PA Arunkumar (1801_CR4) 2012; 2
LM Shelton (1801_CR20) 2013; 84
SE Lee (1801_CR25) 2012; 139
J Yu (1801_CR27) 2015; 8
L Li (1801_CR15) 2014; 2014
J Hoek (1801_CR1) 2016; 8
M Liu (1801_CR9) 2009; 76
Q Lv (1801_CR8) 2016; 36
NA Santos (1801_CR7) 2007; 81
S Noel (1801_CR21) 2015; 88
LM Aleksunes (1801_CR10) 2010; 335
DG Kang (1801_CR16) 2004; 75
YI Chirino (1801_CR6) 2009; 61
GS Oh (1801_CR24) 2014; 85
F Shiraishi (1801_CR23) 2000; 278
L Xu (1801_CR11) 2016; 38
P Cornejo (1801_CR22) 2013; 39
MA Darwish (1801_CR19) 2016; 31
S Latcha (1801_CR2) 2016; 11
CM Chong (1801_CR28) 2013; 543
RP Miller (1801_CR5) 2010; 2
Y Zhang (1801_CR29) 2012; 13
F Ries (1801_CR3) 1986; 8
J Jin (1801_CR18) 2015; 22
J Zhou (1801_CR26) 2014; 9
C Zou (1801_CR17) 2012; 18
X Lu (1801_CR13) 2015; 35
S Guan (1801_CR14) 2013; 8
D Yin (1801_CR12) 2014; 151
22155388 - J Ethnopharmacol. 2012 Jan 31;139(2):541-8
17216432 - Arch Toxicol. 2007 Jul;81(7):495-504
15302225 - Life Sci. 2004 Aug 27;75(15):1801-16
23562886 - Neurosci Lett. 2013 May 24;543:121-5
23783243 - Kidney Int. 2013 Dec;84(6):1090-5
18986801 - Exp Toxicol Pathol. 2009 May;61(3):223-42
24025646 - Kidney Int. 2014 Mar;85(3):547-60
22515799 - J Altern Complement Med. 2012 Apr;18(4):394-401
27550472 - J Biochem Mol Toxicol. 2017 Jan;31(1):1-9
23554160 - Biofactors. 2013 Sep-Oct;39(5):514-21
26838739 - J Huazhong Univ Sci Technolog Med Sci. 2016 Feb;36(1):48-52
20605904 - J Pharmacol Exp Ther. 2010 Oct;335(1):2-12
26649656 - Kidney Int. 2015 Dec;88(6):1217-1218
27355131 - Int Immunopharmacol. 2016 Sep;38:385-94
3538860 - Am J Kidney Dis. 1986 Nov;8(5):368-79
19436334 - Kidney Int. 2009 Aug;76(3):277-85
25981918 - Phytomedicine. 2015 May 15;22(5):528-35
26891330 - Cancers (Basel). 2016 Feb 16;8(2):null
10807584 - Am J Physiol Renal Physiol. 2000 May;278(5):F726-36
22069563 - Toxins (Basel). 2010 Nov;2(11):2490-518
26237835 - J Tradit Chin Med. 2015 Jun;35(3):306-11
23202971 - Int J Mol Sci. 2012 Oct 22;13(10):13621-66
27073199 - Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1173-9
26628961 - Int J Clin Exp Med. 2015 Sep 15;8(9):14793-804
24066136 - PLoS One. 2013 Sep 16;8(9):e74318
24991814 - PLoS One. 2014 Jul 03;9(7):e101668
24269771 - J Ethnopharmacol. 2014;151(1):667-74
23569986 - Asian Pac J Trop Biomed. 2012 Aug;2(8):640-4
24696648 - ScientificWorldJournal. 2014 Feb 13;2014:572697
References_xml – volume: 8
  start-page: e74318
  issue: 9
  year: 2013
  ident: CR14
  article-title: Danshen (Salvia miltiorrhiza) injection suppresses kidney injury induced by iron overload in mice
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0074318
– volume: 335
  start-page: 2
  issue: 1
  year: 2010
  end-page: 12
  ident: CR10
  article-title: Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.110.170084
– volume: 36
  start-page: 48
  issue: 1
  year: 2016
  end-page: 52
  ident: CR8
  article-title: Biliverdin protects against cisplatin-induced apoptosis of renal tubular epithelial cells
  publication-title: J Huazhong Univ Sci Technol Med Sci
  doi: 10.1007/s11596-016-1540-8
– volume: 18
  start-page: 394
  issue: 4
  year: 2012
  end-page: 401
  ident: CR17
  article-title: Chinese herbal medicine Danshen formulations for preventing renal disease in Henoch-Schonlein Purpura: a systematic review and meta-analysis
  publication-title: J Altern Complement Med
  doi: 10.1089/acm.2011.0041
– volume: 75
  start-page: 1801
  issue: 15
  year: 2004
  end-page: 1816
  ident: CR16
  article-title: Lithospermic acid B isolated from Salvia miltiorrhiza ameliorates ischemia/reperfusion-induced renal injury in rats
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2004.02.034
– volume: 84
  start-page: 1090
  issue: 6
  year: 2013
  end-page: 1095
  ident: CR20
  article-title: Role of Nrf2 in protection against acute kidney injury
  publication-title: Kidney Int
  doi: 10.1038/ki.2013.248
– volume: 88
  start-page: 1217
  issue: 6
  year: 2015
  end-page: 1218
  ident: CR21
  article-title: Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases
  publication-title: Kidney Int
  doi: 10.1038/ki.2015.328
– volume: 22
  start-page: 528
  issue: 5
  year: 2015
  end-page: 535
  ident: CR18
  article-title: Protective effect of Wuzhi tablet (Schisandra sphenanthera extract) against cisplatin-induced nephrotoxicity via Nrf2-mediated defense response
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2015.03.003
– volume: 81
  start-page: 495
  issue: 7
  year: 2007
  end-page: 504
  ident: CR7
  article-title: Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-006-0173-2
– volume: 31
  start-page: 1
  issue: 1
  year: 2016
  end-page: 9
  ident: CR19
  article-title: Vitamin E mitigates cisplatin-induced nephrotoxicity due to reversal of oxidative/nitrosative stress, suppression of inflammation and reduction of total renal platinum accumulation
  publication-title: J Biochem Mol Toxic
– volume: 39
  start-page: 514
  issue: 5
  year: 2013
  end-page: 521
  ident: CR22
  article-title: Nrf2-regulated phase-II detoxification enzymes and phase-III transporters are induced by thyroid hormone in rat liver
  publication-title: Biofactors
  doi: 10.1002/biof.1094
– volume: 35
  start-page: 306
  issue: 3
  year: 2015
  end-page: 311
  ident: CR13
  article-title: Danshen (Radix Salviae Miltiorrhizae) reverses renal injury induced by myocardial infarction
  publication-title: J Tradit Chin Med
  doi: 10.1016/S0254-6272(15)30102-3
– volume: 9
  start-page: e101668
  issue: 7
  year: 2014
  ident: CR26
  article-title: Salvianolic acid B attenuates toxin-induced neuronal damage via Nrf2-dependent glial cells-mediated protective activity in Parkinson's disease models
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0101668
– volume: 61
  start-page: 223
  issue: 3
  year: 2009
  end-page: 242
  ident: CR6
  article-title: Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity
  publication-title: Exp Toxicol Pathol
  doi: 10.1016/j.etp.2008.09.003
– volume: 8
  start-page: 21
  issue: 2
  year: 2016
  ident: CR1
  article-title: Nephrotoxicity as a dose-limiting factor in a high-dose cisplatin-based chemoradiotherapy regimen for head and neck carcinomas
  publication-title: Cancers
  doi: 10.3390/cancers8020021
– volume: 139
  start-page: 541
  issue: 2
  year: 2012
  end-page: 548
  ident: CR25
  article-title: Extract of Salvia miltiorrhiza (Danshen) induces Nrf2-mediated heme oxygenase-1 expression as a cytoprotective action in RAW 264.7 macrophages
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2011.11.046
– volume: 13
  start-page: 13621
  issue: 10
  year: 2012
  end-page: 13666
  ident: CR29
  article-title: Tanshinones: sources, pharmacokinetics and anti-cancer activities
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms131013621
– volume: 2
  start-page: 640
  issue: 8
  year: 2012
  end-page: 644
  ident: CR4
  article-title: Science behind cisplatin-induced nephrotoxicity in humans: a clinical study
  publication-title: Asian Pac J Trop Biomed
  doi: 10.1016/S2221-1691(12)60112-9
– volume: 543
  start-page: 121
  year: 2013
  end-page: 125
  ident: CR28
  article-title: Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells and dopaminergic neurons in zebrafish
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2013.02.069
– volume: 85
  start-page: 547
  issue: 3
  year: 2014
  end-page: 560
  ident: CR24
  article-title: Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice
  publication-title: Kidney Int
  doi: 10.1038/ki.2013.330
– volume: 11
  start-page: 1173
  issue: 7
  year: 2016
  end-page: 1179
  ident: CR2
  article-title: Long-term renal outcomes after cisplatin treatment
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.08070715
– volume: 278
  start-page: F726
  issue: 5
  year: 2000
  end-page: F736
  ident: CR23
  article-title: Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.2000.278.5.F726
– volume: 8
  start-page: 14793
  issue: 9
  year: 2015
  end-page: 14804
  ident: CR27
  article-title: Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling
  publication-title: Int J Clin Exp Med
– volume: 2014
  start-page: 572697
  year: 2014
  ident: CR15
  article-title: Salvia miltiorrhiza injection ameliorates renal damage induced by lead exposure in mice
  publication-title: Scientific World Journal
– volume: 2
  start-page: 2490
  issue: 11
  year: 2010
  end-page: 2518
  ident: CR5
  article-title: Mechanisms of cisplatin nephrotoxicity
  publication-title: Toxins
  doi: 10.3390/toxins2112490
– volume: 38
  start-page: 385
  year: 2016
  end-page: 394
  ident: CR11
  article-title: Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2016.06.024
– volume: 151
  start-page: 667
  issue: 1
  year: 2014
  end-page: 674
  ident: CR12
  article-title: Renoprotection of Danshen Injection on streptozotocin-induced diabetic rats, associated with tubular function and structure
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2013.11.025
– volume: 8
  start-page: 368
  issue: 5
  year: 1986
  end-page: 379
  ident: CR3
  article-title: Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity
  publication-title: Am J Kidney Dis
  doi: 10.1016/S0272-6386(86)80112-3
– volume: 76
  start-page: 277
  issue: 3
  year: 2009
  end-page: 285
  ident: CR9
  article-title: Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice
  publication-title: Kidney Int
  doi: 10.1038/ki.2009.157
– volume: 139
  start-page: 541
  issue: 2
  year: 2012
  ident: 1801_CR25
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2011.11.046
– volume: 36
  start-page: 48
  issue: 1
  year: 2016
  ident: 1801_CR8
  publication-title: J Huazhong Univ Sci Technol Med Sci
  doi: 10.1007/s11596-016-1540-8
– volume: 2
  start-page: 640
  issue: 8
  year: 2012
  ident: 1801_CR4
  publication-title: Asian Pac J Trop Biomed
  doi: 10.1016/S2221-1691(12)60112-9
– volume: 76
  start-page: 277
  issue: 3
  year: 2009
  ident: 1801_CR9
  publication-title: Kidney Int
  doi: 10.1038/ki.2009.157
– volume: 543
  start-page: 121
  year: 2013
  ident: 1801_CR28
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2013.02.069
– volume: 11
  start-page: 1173
  issue: 7
  year: 2016
  ident: 1801_CR2
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.08070715
– volume: 2
  start-page: 2490
  issue: 11
  year: 2010
  ident: 1801_CR5
  publication-title: Toxins
  doi: 10.3390/toxins2112490
– volume: 61
  start-page: 223
  issue: 3
  year: 2009
  ident: 1801_CR6
  publication-title: Exp Toxicol Pathol
  doi: 10.1016/j.etp.2008.09.003
– volume: 39
  start-page: 514
  issue: 5
  year: 2013
  ident: 1801_CR22
  publication-title: Biofactors
  doi: 10.1002/biof.1094
– volume: 151
  start-page: 667
  issue: 1
  year: 2014
  ident: 1801_CR12
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2013.11.025
– volume: 38
  start-page: 385
  year: 2016
  ident: 1801_CR11
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2016.06.024
– volume: 278
  start-page: F726
  issue: 5
  year: 2000
  ident: 1801_CR23
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.2000.278.5.F726
– volume: 31
  start-page: 1
  issue: 1
  year: 2016
  ident: 1801_CR19
  publication-title: J Biochem Mol Toxic
  doi: 10.1002/jbt.21833
– volume: 81
  start-page: 495
  issue: 7
  year: 2007
  ident: 1801_CR7
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-006-0173-2
– volume: 75
  start-page: 1801
  issue: 15
  year: 2004
  ident: 1801_CR16
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2004.02.034
– volume: 85
  start-page: 547
  issue: 3
  year: 2014
  ident: 1801_CR24
  publication-title: Kidney Int
  doi: 10.1038/ki.2013.330
– volume: 35
  start-page: 306
  issue: 3
  year: 2015
  ident: 1801_CR13
  publication-title: J Tradit Chin Med
  doi: 10.1016/S0254-6272(15)30102-3
– volume: 8
  start-page: 21
  issue: 2
  year: 2016
  ident: 1801_CR1
  publication-title: Cancers
  doi: 10.3390/cancers8020021
– volume: 2014
  start-page: 572697
  year: 2014
  ident: 1801_CR15
  publication-title: Scientific World Journal
– volume: 335
  start-page: 2
  issue: 1
  year: 2010
  ident: 1801_CR10
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.110.170084
– volume: 8
  start-page: 14793
  issue: 9
  year: 2015
  ident: 1801_CR27
  publication-title: Int J Clin Exp Med
– volume: 13
  start-page: 13621
  issue: 10
  year: 2012
  ident: 1801_CR29
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms131013621
– volume: 22
  start-page: 528
  issue: 5
  year: 2015
  ident: 1801_CR18
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2015.03.003
– volume: 8
  start-page: e74318
  issue: 9
  year: 2013
  ident: 1801_CR14
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0074318
– volume: 84
  start-page: 1090
  issue: 6
  year: 2013
  ident: 1801_CR20
  publication-title: Kidney Int
  doi: 10.1038/ki.2013.248
– volume: 9
  start-page: e101668
  issue: 7
  year: 2014
  ident: 1801_CR26
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0101668
– volume: 18
  start-page: 394
  issue: 4
  year: 2012
  ident: 1801_CR17
  publication-title: J Altern Complement Med
  doi: 10.1089/acm.2011.0041
– volume: 88
  start-page: 1217
  issue: 6
  year: 2015
  ident: 1801_CR21
  publication-title: Kidney Int
  doi: 10.1038/ki.2015.328
– volume: 8
  start-page: 368
  issue: 5
  year: 1986
  ident: 1801_CR3
  publication-title: Am J Kidney Dis
  doi: 10.1016/S0272-6386(86)80112-3
– reference: 27073199 - Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1173-9
– reference: 19436334 - Kidney Int. 2009 Aug;76(3):277-85
– reference: 22515799 - J Altern Complement Med. 2012 Apr;18(4):394-401
– reference: 23562886 - Neurosci Lett. 2013 May 24;543:121-5
– reference: 17216432 - Arch Toxicol. 2007 Jul;81(7):495-504
– reference: 20605904 - J Pharmacol Exp Ther. 2010 Oct;335(1):2-12
– reference: 22155388 - J Ethnopharmacol. 2012 Jan 31;139(2):541-8
– reference: 26628961 - Int J Clin Exp Med. 2015 Sep 15;8(9):14793-804
– reference: 24696648 - ScientificWorldJournal. 2014 Feb 13;2014:572697
– reference: 15302225 - Life Sci. 2004 Aug 27;75(15):1801-16
– reference: 26237835 - J Tradit Chin Med. 2015 Jun;35(3):306-11
– reference: 27355131 - Int Immunopharmacol. 2016 Sep;38:385-94
– reference: 24025646 - Kidney Int. 2014 Mar;85(3):547-60
– reference: 18986801 - Exp Toxicol Pathol. 2009 May;61(3):223-42
– reference: 23554160 - Biofactors. 2013 Sep-Oct;39(5):514-21
– reference: 24269771 - J Ethnopharmacol. 2014;151(1):667-74
– reference: 27550472 - J Biochem Mol Toxicol. 2017 Jan;31(1):1-9
– reference: 23783243 - Kidney Int. 2013 Dec;84(6):1090-5
– reference: 23569986 - Asian Pac J Trop Biomed. 2012 Aug;2(8):640-4
– reference: 24991814 - PLoS One. 2014 Jul 03;9(7):e101668
– reference: 26891330 - Cancers (Basel). 2016 Feb 16;8(2):null
– reference: 3538860 - Am J Kidney Dis. 1986 Nov;8(5):368-79
– reference: 24066136 - PLoS One. 2013 Sep 16;8(9):e74318
– reference: 25981918 - Phytomedicine. 2015 May 15;22(5):528-35
– reference: 22069563 - Toxins (Basel). 2010 Nov;2(11):2490-518
– reference: 26838739 - J Huazhong Univ Sci Technolog Med Sci. 2016 Feb;36(1):48-52
– reference: 26649656 - Kidney Int. 2015 Dec;88(6):1217-1218
– reference: 23202971 - Int J Mol Sci. 2012 Oct 22;13(10):13621-66
– reference: 10807584 - Am J Physiol Renal Physiol. 2000 May;278(5):F726-36
SSID ssj0057624
ssib031263182
ssj0002039635
ssib051367596
ssib034325102
Score 2.186353
Snippet Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of...
Summary Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect...
Danshen,an efficacious agent for cardiovascular diseases,has been found to play an essential role in kidney injury.In the present study,the effect of Danshen...
SourceID wanfang
proquest
pubmed
crossref
springer
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 761
SubjectTerms Medicine
Medicine & Public Health
Title Danshen Modulates Nrf2-mediated Signaling Pathway in Cisplatin-induced Renal Injury
URI http://lib.cqvip.com/qk/85740A/201705/673963609.html
https://link.springer.com/article/10.1007/s11596-017-1801-1
https://www.ncbi.nlm.nih.gov/pubmed/29058292
https://www.proquest.com/docview/1954423170
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e201705019
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFeEHfKYArSnkBGjnN_7CamCml7WSeVp8hJbNYC6Wgbse2H8Hs5x3acdIOJ8RK1keO6Pl_OxedGyJ4EGSZVxqjvJzEFCZHSgrOUpqFSqWQiUroXwdFxPD4NP02j6WDwqxe11KyLD-XVH_NK_oeqcA_oilmyd6CsmxRuwGegL1yBwnD9JxoDyVZnssZ2NtiFSwLPWipOdTYIapIYnCFMvjkoej-FzvErZ6tzDICrKZjjDbr_l7LWpTfmzWZ-dFu76bt15lhp2bkt9DHryYyuZo55CBuMLxYOMItGe0BgofSyw-KBTQv53MpOe_QA4qwNYjNgGTfi6gw7Im3GkLRMCQ_-r_kHNF_jYDWh_WvcMdLcg-8UTL9pnzGbajAWgFGPyyamfrsV2IlpNnFDFjCbGw0KGx6awOpBGlO_E3wuHLEr3Yxjcxib49gcrOptDuYH8M_t0eH-_nHLqQKfx8AMnWKI2blRrxBbhIXwIlvIcG7cvcDpMJ7W_fvWxa7zOK-tEQt94M7-ABJsKkw3rKCeB1_nndVK1F96KtLkEXlobRtvZID6mAxk_YTcP7LRG0_JicWr5_DqbeDVc3j1LF69We3dwKun8eoZvD4jk8OPk4MxtU09aBmyZE2TuBIpqLFVXPI4hc1VhQqUL5ksuQwzkRR-zIWUvpIK9lklaVWxoIqB1fhFJYLnZKte1PIl8STY_mUSwwNZFJahSFlZJjBTIALBQS0fkh23ifm5qd2CYYwZlsjLhoS125qXthw-dmX5lv8VDUPyzj3SznfL4LctrXLg2OiGE7VcNKsclwtGjJ-wIXlhiOim4xmLUp7xIXnfUjW3DGd122_tWcJ3g9fzy6_VxUWRS65LZoEp9-pOk-6QB907_5psrZeNfAMK-LrYtW_DLrl3yke_AaQE0bs
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Danshen+modulates+Nrf2-mediated+signaling+pathway+in+cisplatin-induced+renal+injury&rft.jtitle=Current+medical+science&rft.au=Cao%2C+Si-si&rft.au=Yan%2C+Miao&rft.au=Hou%2C+Zhen-yan&rft.au=Chen%2C+Ying&rft.date=2017-10-01&rft.pub=Huazhong+University+of+Science+and+Technology&rft.issn=2096-5230&rft.eissn=2523-899X&rft.volume=37&rft.issue=5&rft.spage=761&rft.epage=765&rft_id=info:doi/10.1007%2Fs11596-017-1801-1&rft.externalDocID=10_1007_s11596_017_1801_1
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg